Cargando…

Monoclonal Antibodies against Epidermal Growth Factor Receptor in Solid Tumors

Detalles Bibliográficos
Autores principales:	Saba, Nabil F., Yom, Sue S., Haigentz, Missak, El-Rayes, Bassel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2012
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3540736/ https://www.ncbi.nlm.nih.gov/pubmed/23320170 http://dx.doi.org/10.1155/2012/291421

Ejemplares similares

EGFR Monoclonal Antibodies in the Treatment of Squamous Cell Carcinoma of the Head and Neck: A View beyond Cetuximab
por: Kono, Scott A., et al.
Publicado: (2012)

Dermatologic Toxicities from Monoclonal Antibodies and Tyrosine Kinase Inhibitors against EGFR: Pathophysiology and Management
por: Abdullah, Shaad E., et al.
Publicado: (2012)

Monoclonal antibody against the fusion junction of a deletion-mutant epidermal growth factor receptor.
por: Okamoto, S., et al.
Publicado: (1996)

Targeting the epidermal growth factor receptor
por: El-Rayes, B F, et al.
Publicado: (2004)

A phase Ia dose-escalation trial of Ametumumab (a fully human monoclonal antibody against epidermal growth factor receptor) in patients with advanced solid malignancies
por: Li, Da, et al.
Publicado: (2023)

The Use of Epidermal Growth Factor Receptor Monoclonal Antibodies in Squamous Cell Carcinoma of the Head and Neck
por: Russell, Jeffery S., et al.
Publicado: (2012)

Radiosensitisation of U87MG brain tumours by anti-epidermal growth factor receptor monoclonal antibodies
por: Diaz Miqueli, A, et al.
Publicado: (2009)

An insulin growth factor-I/II-neutralizing monoclonal antibody in combination with epidermal growth factor receptor inhibitors potently inhibits tumor cell growth
por: Ma, Guofang, et al.
Publicado: (2022)

Affinity Maturation of an Epidermal Growth Factor Receptor Targeting Human Monoclonal Antibody ER414 by CDR Mutation
por: Chang, Ki-Hwan, et al.
Publicado: (2012)

Resistant metastatic penile carcinoma and response to biochemotherapy with paclitaxel and epidermal growth factor receptor monoclonal antibody, nimotuzumab
por: Pandey, Avinash, et al.
Publicado: (2013)

Management of dermatologic toxicities associated with monoclonal antibody epidermal growth factor receptor inhibitors: A case review
por: Leporini, Christian, et al.
Publicado: (2013)

Chimeric Monoclonal Antibody Cetuximab Targeting Epidermal Growth Factor-Receptor in Advanced Non-Melanoma Skin Cancer
por: Wollina, Uwe, et al.
Publicado: (2017)

The Efficacy and Safety of Anti-epidermal Growth Factor Receptor Monoclonal Antibodies in Nasopharyngeal Carcinoma: Literature-based Meta-analyses
por: Peng, Liang, et al.
Publicado: (2018)

Erratum to: Insulin-like growth factor 1 receptor mediated tyrosine 845 phosphorylation of epidermal growth factor receptor in the presence of monoclonal antibody cetuximab
por: Iyer, Gopal, et al.
Publicado: (2016)

Monoclonal antibodies and Fc fragments for treating solid tumors
por: Eisenbeis, Andrea M, et al.
Publicado: (2012)

Special Issue: Monoclonal Antibodies
por: Klein, Christian
Publicado: (2018)

Epidermal Growth Factor Receptor: A Novel Target for Anticancer Treatment
por: Pandey, Manoj, et al.
Publicado: (2003)

Therapeutic Monoclonal Antibodies and Emergence of Their Biosimilars
por: Jeddi-Tehrani, Mahmood
Publicado: (2018)

Strategies to enhance monoclonal antibody uptake and distribution in solid tumors
por: Bordeau, Brandon M., et al.
Publicado: (2021)

Enhancement of the antitumor activity of ionising radiation by nimotuzumab, a humanised monoclonal antibody to the epidermal growth factor receptor, in non-small cell lung cancer cell lines of differing epidermal growth factor receptor status
por: Akashi, Y, et al.
Publicado: (2008)

Immunohistochemical Characterization of Three Monoclonal Antibodies Raised against the Epidermal Growth Factor and Its Receptor in Non-Small-Cell Lung Cancer: Their Potential Use in the Selection of Patients for Immunotherapy
por: Rengifo, Charles E., et al.
Publicado: (2013)

Adjuvant epidermal growth factor receptor tyrosine kinase inhibitors: are we actually ready?
por: Tabbò, Fabrizio, et al.
Publicado: (2020)

Inhibition of parasite invasion by monoclonal antibody against epidermal growth factor-like domain of Plasmodium vivax merozoite surface protein 1 paralog
por: Han, Jin-Hee, et al.
Publicado: (2019)

Monoclonal Antibody a Promising Treatment for Depression
por: Akhondzadeh, Shahin
Publicado: (2019)

Epidermal growth factor receptor double targeting by a tyrosine kinase inhibitor (Iressa) and a monoclonal antibody (Cetuximab). Impact on cell growth and molecular factors
por: Fischel, J-L, et al.
Publicado: (2005)

A novel therapeutic strategy of personalized medicine based on anti-epidermal growth factor receptor monoclonal antibodies in patients with metastatic colorectal cancer
por: Matsuhashi, Nobuhisa, et al.
Publicado: (2018)

Development of EMab-51, a Sensitive and Specific Anti-Epidermal Growth Factor Receptor Monoclonal Antibody in Flow Cytometry, Western Blot, and Immunohistochemistry
por: Itai, Shunsuke, et al.
Publicado: (2017)

Anti‐epidermal growth factor receptor monoclonal antibody plus palliative chemotherapy as a first‐line treatment for recurrent or metastatic nasopharyngeal carcinoma
por: Chen, Chen, et al.
Publicado: (2020)

The distribution of the therapeutic monoclonal antibodies cetuximab and trastuzumab within solid tumors
por: Lee, Carol M, et al.
Publicado: (2010)

Therapeutic Monoclonal Antibodies Targeting Immune Checkpoints for the Treatment of Solid Tumors
por: Gravbrot, Nicholas, et al.
Publicado: (2019)

Leading Edge: Intratumor Delivery of Monoclonal Antibodies for the Treatment of Solid Tumors
por: Blanco, Ester, et al.
Publicado: (2023)

Response assessment after induction chemotherapy for head and neck squamous cell carcinoma: From physical examination to modern imaging techniques and beyond
por: de Bree, Remco, et al.
Publicado: (2017)

Potential Prognostic and Diagnostic Application of a Novel Monoclonal Antibody Against Keratinocyte Growth Factor Receptor
por: Ceccarelli, Simona, et al.
Publicado: (2014)

Monoclonal Antibody for Reducing Memory and Learning Problems in Schizophrenia
por: Akhondzadeh, Shahin
Publicado: (2018)

Incidence and risk of severe infections associated with anti-epidermal growth factor receptor monoclonal antibodies in cancer patients: a systematic review and meta-analysis
por: Qi, Wei-Xiang, et al.
Publicado: (2014)

Quality of Life in Patients With Severe Skin Reactions in Course of First-Generation Epidermal Growth Factor Receptor Inhibitors Monoclonal Antibodies (Our Experience With Cetuximab)
por: De Luca, Rossella, et al.
Publicado: (2021)

Monoclonal Antibodies to the Thyrotropin Receptor
por: Ando, Takao, et al.
Publicado: (2005)

Results from the Children’s Oncology Group phase III trial of a monoclonal antibody against the insulin-like growth factor-1 receptor in patients with newly diagnosed metastatic Ewing sarcoma
por: Carcaboso, Angel M.
Publicado: (2023)

Therapeutic antitumor efficacy of anti-epidermal growth factor receptor antibody, cetuximab, against malignant pleural mesothelioma
por: KURAI, JUN, et al.
Publicado: (2012)

Molecular imaging of a fluorescent antibody against epidermal growth factor receptor detects high-grade glioma
por: Zhou, Quan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_fsn5otmouj77fq0va633nqubtd